The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
The Business Standard's Smart Investor (SI) reports focus on in-depth analysis and timely news concerning strategic investment trends, business deals, and financial manoeuvres within the corporate world.
The stock surged 13% to Rs 86.35 on BSE in intra-day trade.
The stock moved higher by 12% to Rs 902 on BSE on back of heavy volumes.
Markets continued to trade firm led by index heavyweights ITC and ICICI Bank
The stock dipped 6.5% to Rs 1,536 on BSE in intra-day trade.
The stock was up 3% to Rs 257 on BSE in intra-day trade, extending its 5% gain in past two trading sessions.
OCL India hits a record high of Rs 997, up 7% and Dalmia Bharat was up 2.6% at Rs 2,043 on BSE in early morning trade.
PNB Housing Finance listed at 11% premium to issue price of Rs 775 on the BSE
The stock rallied 20% to Rs 840 on BSE after the company reported profit of Rs 31 crore in Q2FY17 against Rs 7 crore in Q2FY16.
The stock hit an intra-day high of Rs 903, after listing at Rs 863, an 11% premium over its issue price of Rs 775 per share.
The stock was up 6% at Rs 1,509 on BSE, as compared to 0.8% rise in the S&P BSE Sensex att 09:26 am.
Sun Pharma, Dr Reddy's, Jubilant Life, Strides Shasun, Aurobindo Pharma were down 5% each over possible US probe into cartelisation
The stock soared 20% to Rs 37.40 in intra-day trade, up 44% in past two trading days from Rs 26 on Nov 2.
The stock dipped 6% to Rs 208 in intra-day trade, extending its yesterday's 17% fall on BSE.
Golden Tobacco locked in upper circuit of 10% and Godfrey Phillips India up 6% on BSE in intra-day trade.
The BSE Mid-Cap index was currently off 1%. The BSE Small-Cap index was currently off 1.94%
Pharma shares were among the top losers with Sun Pharma declining the most
Post Q2FY17 results, in past six trading sessions the stock fallen 10% against 2% fall in S&P BSE Sensex.
Dr Reddys, Sun Pharma, Lupin, Glenmark Pharma and Cadila Healthcare were down between 4% and 5% on the NSE.
A combined 17.91 million equity shares representing 1.96% of total equity of L&T changed hands on the NSE and BSE till 09:43 am.
The stock dipped 10% to Rs 5,850 on the NSE in intra-day trade.